Average Co-Inventor Count = 7.77
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (48 from 923 patents)
2. Gilead Pharmasset LLC (4 from 79 patents)
3. Essential Therapeutics, Inc. (3 from 12 patents)
4. Daiichi Pharmaceutical Co., Ltd. (1 from 200 patents)
5. Trine Pharmaceuticals, Inc. (1 from 2 patents)
56 patents:
1. 12338233 - PD-1/Pd-L1 inhibitors
2. 12269812 - PD-1/PD-L1 inhibitors
3. 11555029 - PD-1/PD-L1 inhibitors
4. 11352329 - HIV protease inhibitors
5. 11318119 - HIV protease inhibitors
6. 10988498 - Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs
7. 10899735 - PD-1/PD-L1 inhibitors
8. 10774053 - HIV protease inhibitors
9. 10774071 - PD-1/PD-L1 inhibitors
10. 10710986 - PD-1/PD-L1 inhibitors
11. 10023600 - Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs
12. 9981955 - Antiviral compounds
13. RE46762 - 1'-substituted carba-nucleoside analogs for antiviral treatment
14. 9511056 - Antiviral compounds
15. 9487544 - Methods for the preparation of diasteromerically pure phosphoramidate prodrugs